NCT05199896 Touching the World With a Cane: Cognitive and Neural Processes
| NCT ID | NCT05199896 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Hospices Civils de Lyon |
| Condition | Visual Impairment |
| Study Type | INTERVENTIONAL |
| Enrollment | 300 participants |
| Start Date | 2022-04-20 |
| Primary Completion | 2028-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 300 participants in total. It began in 2022-04-20 with a primary completion date of 2028-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The use of tools is ubiquitous in our lives and allows us to expand the sensorimotor capacities of our body. Much research has been done on the subject in sighted people over the past decades. This work has mainly focused on the motor aspect of using the tool, neglecting the sensory aspect. However, any action involving a tool carries sensory information, for example in the use of the white cane by blind people. 26% (\> 200,000) of blind people in France use a white cane to get around. By sweeping the cane on the ground, they use it as a sensorimotor extension of their body to extract information from the environment in order to locate a pedestrian crossing or possible obstacles. While it is well established that the tools increase the user's motor skills, we have only just begun to clarify how they also function as sensory extensions of the user's body and how this phenomenon is potentially dependent on constant use of the tool to compensate for a missing sense, as is the case with blind people using a cane. The aim of this study is to fill this important gap in our knowledge.
Eligibility Criteria
Inclusion Criteria: * Man or woman, aged 18 to 60 years old * Give an informed consent by signature * Be part of the national health security system (registered to the Securité Sociale) * do not confuse his right and his left Specific of the non-sighted participants: * Loss of vision happened at birth or 3-to 5 years later minimum in life * Must have a visual acuity inferior or equal to 4/10 * Be with a close relation for read information letter and sign the consent form if needed Exclusion Criteria: * A person presenting an history of neurological, psychiatric or linguistic problems cannot be admitted * Assumption of psychotropic drugs * Pregnancy or breast-feeding woman * A person under legal tutoring * A person under care in other medical structure for reasons different from those of this research * A person under administrative or judiciary contention * A person who is not eligible to a MRI-exam according to the following criteria cannot be admitted to the experiments including MR acquisitions : * Have a neurological, cardiac (battery) or defibrillator pacemaker * Have a cardiac prosthesis (valve, stent...) or vascular prosthesis * Have intracranial clips or clamps * Carry a bypass of the cerebrospinal fluid * Having metallic splinters in the eyes * Wear metal prostheses (teeth, knees) * Wear an infusion pump or system * Be claustrophobic or have respiratory problems * Have metal tattoos close to the head * Have permanent make-up
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05199896 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 60 Years, studying Visual Impairment. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05199896 currently recruiting?
Yes, NCT05199896 is actively recruiting participants. Contact the research team at alessandro.farne@inserm.fr for enrollment information.
Where is the NCT05199896 trial being conducted?
This trial is being conducted at Bron, France.
Who is sponsoring the NCT05199896 clinical trial?
NCT05199896 is sponsored by Hospices Civils de Lyon. The trial plans to enroll 300 participants.